Epsilon Healthcare Ltd (EPN) - Total Liabilities
Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) has total liabilities worth AU$15.59 Million AUD (≈ $11.03 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Epsilon Healthcare Ltd (EPN) long-term investment share to see how much of total assets are deployed in long-term investments.
Epsilon Healthcare Ltd - Total Liabilities Trend (2016–2025)
This chart illustrates how Epsilon Healthcare Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Epsilon Healthcare Ltd balance sheet assets.
Epsilon Healthcare Ltd Competitors by Total Liabilities
The table below lists competitors of Epsilon Healthcare Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Idealist Gayrimenkul Yatirim Ortakligi AS
IS:IDGYO
|
Turkey | TL587.56 Million |
|
HEBEI YICHEN GRP H YC 05
F:HE2
|
Germany | €1.15 Billion |
|
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX
|
USA | $185.96K |
|
ECP Emerging Growth Ltd
AU:ECP
|
Australia | AU$10.43 Million |
|
ARB IOT Group Limited Ordinary Shares
NASDAQ:ARBB
|
USA | $16.25 Million |
|
Jcurve Solutions Ltd
AU:JCS
|
Australia | AU$7.10 Million |
|
Gaxos.ai Inc
NASDAQ:GXAI
|
USA | $1.13 Million |
|
SynBiotic SE
F:SBX
|
Germany | €17.83 Million |
Liability Composition Analysis (2016–2025)
This chart breaks down Epsilon Healthcare Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See EPN equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.80 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Epsilon Healthcare Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Epsilon Healthcare Ltd (2016–2025)
The table below shows the annual total liabilities of Epsilon Healthcare Ltd from 2016 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | AU$15.95 Million ≈ $11.29 Million |
+37.94% |
| 2024-12-31 | AU$11.57 Million ≈ $8.18 Million |
+68.29% |
| 2023-12-31 | AU$6.87 Million ≈ $4.86 Million |
-38.80% |
| 2022-12-31 | AU$11.23 Million ≈ $7.95 Million |
+2.27% |
| 2021-12-31 | AU$10.98 Million ≈ $7.77 Million |
-8.06% |
| 2020-12-31 | AU$11.94 Million ≈ $8.45 Million |
+117.47% |
| 2019-12-31 | AU$5.49 Million ≈ $3.89 Million |
+17.90% |
| 2018-12-31 | AU$4.66 Million ≈ $3.30 Million |
+691.15% |
| 2017-12-31 | AU$588.83K ≈ $416.63K |
+403.30% |
| 2016-12-31 | AU$116.99K ≈ $82.78K |
-- |
About Epsilon Healthcare Ltd
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturi… Read more